Ge Long Hui A P P·2025-12-01 08:44Core Viewpoint - The approval of ultrasound products by United Imaging Healthcare (联影医疗) for NMPA registration enhances the company's medical imaging product matrix and is expected to drive new revenue growth opportunities [1] Company Summary - The newly approved ultrasound products cover a full range of categories including ultra-high-end, high-end, mid-range, and economical models, applicable in various departments such as cardiology, obstetrics, and emergency care [1] - The company is anticipated to see significant revenue growth in Q4, supported by a high level of industry bidding activity and the recognition of domestic orders from the first three quarters [1] - The introduction of high-end products like 5.0T MR, uMI Panorama, and photon-counting spectral CT is expected to contribute to steady revenue and net profit growth in the coming year [1] Industry Summary - The medical imaging industry is projected to maintain a favorable outlook due to ongoing equipment upgrade projects and strong growth in overseas markets [1] - The overall profit margin for the company is expected to improve significantly throughout 2025, driven by the anticipated performance in Q4 and beyond [1]